Stress‐induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin
- 11 April 2008
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 27 (8) , 2147-2155
Abstract
Stress‐induced analgesia (SIA) is an important endogenous mechanism in response to stressful stimuli. Opioid peptides, as well as endocannabinoids, are known mediators of SIA. We were interested in whether the endocannabinoid tone and the resulting SIA could be influenced by changing the activity of cholecystokinin (CCK) in mice. This hypothesis is related to recent evidence showing a cellular colocalization of neuropeptide CCK and cannabinoid type 1 (CB1) receptors in many central nervous system structures. However, the physiological relevance of this colocalization is unknown. Our aim was to test whether abolishing the endogenous CCK tone might influence the cannabinoid‐mediated form of SIA. As expected, the CB1 antagonist rimonabant prevented the development of analgesia in response to footshock‐induced stress in wild‐type mice. In contrast, CCK type 2 (CCK2) receptor‐deficient mice developed SIA regardless of rimonabant treatment. Naloxone, an opioid antagonist, antagonized SIA in both wild‐type and CCK2 receptor‐deficient homozygous mice. This finding suggests that CCK, through CCK2 receptors, modulates the action of endocannabinoids. Gene expression analysis revealed an up‐regulation of CCK2 receptor gene in the lumbar spinal cord and mesolimbic area in wild‐type mice in response to stress. In addition, wild‐type mice displayed up‐regulation of genes implicated in endocannabinoid‐mediated neurotransmission (elevation of CB1 receptor, 2‐arachidonoylglycerol and the anandamide‐synthesizing enzymes sn‐1‐diacylglycerol lipase alpha and N‐acyl‐phosphatidylethanolamine‐hydrolysing phospholipase D) in response to stress in the lumbar spinal cord and mesolimbic area. We did not find any of these changes in CCK2 receptor‐deficient homozygous mice. Altogether, behavioural and gene expression studies reflect an involvement of CCK2 receptors in the development of endocannabinoid‐mediated SIA.Keywords
This publication has 31 references indexed in Scilit:
- Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesiaNeuropharmacology, 2006
- Suppression of the morphine‐induced rewarding effect in the rat with neuropathic pain: implication of the reduction in µ‐opioid receptor functions in the ventral tegmental areaJournal of Neurochemistry, 2002
- Cholecystokinin and morphine analgesia: variations on a themeTrends in Pharmacological Sciences, 1994
- Regional Distribution of Calcitonin Gene‐Related Peptide‐, Substance P‐, Cholecystokinin‐, Met5‐Enkephalin‐, and Dynorphin A (1–8)‐Like Materials in the Spinal Cord and Dorsal Root Ganglia of Adult Rats: Effects of Dorsal Rhizotomy and Neonatal CapsaicinJournal of Neurochemistry, 1990
- The role of CCK, caerulein, and CCK antagonists in nociceptionPain, 1989
- The Many Possible Roles of Opioids and Related Peptides in Stress‐Induced AnalgesiaaAnnals of the New York Academy of Sciences, 1986
- Morphine Analgesia Potentiated But Tolerance Not Affected by Active Immunization Against CholecystokininScience, 1984
- Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin CircuitryAnnual Review of Neuroscience, 1984
- Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin CircuitryAnnual Review of Neuroscience, 1984
- Opioid and Nonopioid Mechanisms of Stress AnalgesiaScience, 1980